12:00 AM
Jan 21, 2013
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Halozyme completes debt financing

Halozyme Therapeutics Inc. (NASDAQ:HALO), San Diego, Calif.
Business: Endocrine/Metabolic, Cancer, Dermatology

Read the full 38 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >